Skip to main content
About
Our Strategy
Our Leadership
Our Board of Directors
Science
Our Platforms
Antibody Platform
PRO-XTEN™ masking technology
Literature Archive
Pipeline
Our Pipeline
Our Therapeutic Focus
Our Collaborators
Careers
Job Opportunities
Contact
Investors
News
Events & Presentations
Stock Info
Stock Quote
Analyst Coverage
Financials
Quarterly Reports
SEC Filings
Governance
Governance Documents
Committee Composition
Whistleblower Hotline
Resources
Investor FAQs
Information Request Form
Investor Email Alerts
Investor Contact
Powering the Immune System
to Transform Lives
Our Leadership
Marianne De Backer,
M.Sc., Ph.D., MBA
Chief Executive Officer and Director
Jeff Calcagno, M.D.
Executive Vice President and Chief Business Officer
Vanina de Verneuil, J.D.
Executive Vice President, General Counsel and Corporate Secretary
Mika Kakefuda Derynck, M.D.
Executive Vice President, Therapeutic Area Head Oncology
Mark Eisner, M.D., M.P.H.
Executive Vice President and Chief Medical Officer
Aine Hanly, Ph.D.
Executive Vice President and Chief Technology Officer
Jason O’Byrne, MBA
Executive Vice President and Chief Financial Officer
Jennifer Eileen Towne, Ph.D.
Executive Vice President and Chief Scientific Officer
Arran Attridge
SENIOR VICE PRESIDENT CORPORATE COMMUNICATIONS
Toby Medaris, M.Sc.
Senior Vice President
Human Resources
Supporting Fellows
Antonio Lanzavecchia, M.D.
SENIOR VICE PRESIDENT AND SENIOR RESEARCH FELLOW
Amalio Telenti, M.D, Ph.D.
EXECUTIVE VICE PRESIDENT AND SENIOR RESEARCH FELLOW
